AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, J. P.
Right arrow Articles by Blair, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, J. P.
Right arrow Articles by Blair, H. C.
Agricola
Right arrow Articles by Williams, J. P.
Right arrow Articles by Blair, H. C.

American Journal of Clinical Nutrition, Vol 68, 1369S-1374S, Copyright © 1998 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Tyrosine kinase inhibitor effects on avian osteoclastic acid transport

JP Williams, SE Jordan, S Barnes and HC Blair
Department of Pathology, University of Alabama at Birmingham, and Veteran's Affairs Medical Center, 35294-0007, USA.

We found that tyrosine kinase pp60(c-src) coisolates with acid- transporting osteoclast membranes and hypothesized that this kinase regulates hydrochloric acid transport. We assayed the membrane acid transport and bone degradation effects of tyrosine kinase inhibitors in avian osteoclasts. Isoflavone, tyrphostin, and benzoquinonoid inhibitors were compared with inactive analogues to determine nonspecific effects. Acid-secreting membranes, isolated by nitrogen cavitation, were assayed as reconstituted vesicles by using acridine orange to indicate ATP-dependent hydrogen ion transport. The soy isoflavone genistein and the benzoquinonoid antibiotic herbimycin inhibited hydrochloric acid transport with 50% inhibition at approximately 10 and approximately 2 micromol/L, respectively; effects appeared in <2 min and were reversible. In membrane incubated with inhibitors, the herbimycin effect also inhibited Cl- transport by variable amounts, suggesting that this compound affects Cl- channel activity. However, genistein and tyrphostins did not produce chloride dependent effects. After 30 min with ATP, tyrphostin A47 irreversibly inhibited hydrochloric acid transport with 50% inhibition at approximately 10 micromol/L. Tyrphostin A25 and controls, tyrphostin A1 and daidzein (a genistein congener), were inactive despite preincubation. Osteoclastic bone resorption was more sensitive to the inhibitors over 3-5-d assays than was membrane acid transport, except for tyrphostins. Herbimycin and genistein inhibited bone resorption with half maximal effects at 0.5 and 10 micromol/L and complete inhibition at 3 d in 1 and 20 micromol/L, respectively. None of the tyrphostins, including A47, nor daidzein inhibited resorption to >20 micromol/L. We conclude that tyrosine kinase inhibition directly inhibits osteoclast membrane hydrochloric acid transport; differences among inhibitors may reflect chemical reactivity and permeability.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
H. Marini, L. Minutoli, F. Polito, A. Bitto, D. Altavilla, M. Atteritano, A. Gaudio, S. Mazzaferro, A. Frisina, N. Frisina, et al.
Effects of the Phytoestrogen Genistein on Bone Metabolism in Osteopenic Postmenopausal Women: A Randomized Trial
Ann Intern Med, June 19, 2007; 146(12): 839 - 847.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. M. Weaver and J. M. K. Cheong
Soy Isoflavones and Bone Health: The Relationship Is Still Unclear
J. Nutr., May 1, 2005; 135(5): 1243 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Garcia Palacios, L. J. Robinson, C. W. Borysenko, T. Lehmann, S. E. Kalla, and H. C. Blair
Negative Regulation of RANKL-induced Osteoclastic Differentiation in RAW264.7 Cells by Estrogen and Phytoestrogens
J. Biol. Chem., April 8, 2005; 280(14): 13720 - 13727.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. D. Setchell and E. Lydeking-Olsen
Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 593S - 609.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen
The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones
J. Nutr., December 1, 2002; 132(12): 3577 - 3584.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Picherit, V. Coxam, C. Bennetau-Pelissero, S. Kati-Coulibaly, M.-J. Davicco, P. Lebecque, and J.-P. Barlet
Daidzein Is More Efficient than Genistein in Preventing Ovariectomy-Induced Bone Loss in Rats
J. Nutr., July 1, 2000; 130(7): 1675 - 1681.
[Abstract] [Full Text]


Home page
J. Am. Coll. Nutr.Home page
J. Z. Ilich and J. E. Kerstetter
Nutrition in Bone Health Revisited: A Story Beyond Calcium
J. Am. Coll. Nutr., June 1, 2000; 19(6): 715 - 737.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by The American Society for Nutrition